Project Grant HT94252510819
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$3.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
The University of Massachusetts was awarded a $153,309 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2024, supports research to extend the period of performance for a project titled "Modeling Spread Through Air Spaces with Lung-on-a-Chip". This research aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical...
This $7,707,792 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports RNA-based strategies for the prevention and treatment of alphavirus and hemorrhagic fever virus infections. The grant was awarded on September 15, 2024 to the University of Massachusetts Medical School (UMass Medical) in Worcester, MA. As a prominent research institution, UMass Medical has extensive experience securing...
The University of Massachusetts Medical School was awarded a $5,712,429 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "CRISPR-BASED ADIPOSE THERAPIES FOR ACCELERATED AGING IN IRRADIATED NONHUMAN PRIMATES," will fund advanced biomedical research focused on developing CRISPR-based treatments for accelerated aging in irradiated non-human primates. The award period runs from July 1, 2025, to June...
The University of Massachusetts Medical School was awarded a $749,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to study the role of SCARF1 in efferocytosis and the prevention of lupus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The U.S. Defense Health Agency awarded a $7,349,780 Project Grant to the University of Massachusetts Medical School (UMass Medical) to conduct research on "RNA Therapeutics for Infectious Diseases: Viral Hemorrhagic Fever" over a 4-year period from September 1, 2023 to August 31, 2027. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to develop innovative medical solutions for...
The University of Massachusetts Amherst was awarded a $557,247 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from February 1, 2023 to January 31, 2026 to develop intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The Military Medical Research and Development program supports innovative medical research with...
The Department of the Army Medical Command awarded a $1,559,896 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from September 2022 through August 2026 to define small airways disease as a therapeutic target in post-acute sequelae of COVID-19. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving military and public...
The Department of the Army Medical Command awarded a $1,623,832 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from September 2022 to August 2026 to define small airways disease as a therapeutic target in post-acute sequelae of COVID-19. The Military Medical Research and Development program aims to advance biomedical research that transforms military and public health care. This award will support...
This $952,162 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to develop novel, improved adeno-associated virus (AAV) vectors for the treatment of amyotrophic lateral sclerosis (ALS). The award was granted to the University of Massachusetts Medical School (UMass Medical) in Worcester, MA, with a period of performance from August 1, 2025 to July 31, 2027. UMass Medical, as a prominent academic...
The University of Massachusetts (UMass) has been awarded a $413,118.75 Project Grant from the Defense Health Agency's Military Health Services Research (MHSR) Program (CFDA 12.007). The grant, which runs from September 1, 2024, to August 31, 2026, will fund research to examine the cumulative psychosocial stress and health readiness among military personnel in the Millennium Cohort Study, with a focus on understanding the role of race, ethnicity, and sex disparities. As a major land-grant...